Preoperative Factors Associated with Infiltrative Histologic Growth Patterns in Extremity Soft Tissue Sarcoma
- PMID: 28808411
- PMCID: PMC5541793
- DOI: 10.1155/2017/5419394
Preoperative Factors Associated with Infiltrative Histologic Growth Patterns in Extremity Soft Tissue Sarcoma
Abstract
Soft tissue sarcoma (STS) with an infiltrative histologic growth pattern, when compared to STS with an expansile pattern, may pose difficulties in local control. Preoperative assessment of the presence of infiltrative histologic growth pattern would be helpful in deciding treatment strategies. A review of 144 patients who underwent surgery for extremity STS was performed. Microscopically, the histologic growth pattern was defined as infiltrative if the penetration of the tumor cells into the surrounding tissue was observed. Possible clinicopathologic factors that might be associated with infiltrative histologic growth pattern were investigated with regard to patient demographics, tumor characteristics, and MRI findings. Of the 144 tumors, 71 (49%) showed infiltrative histologic growth pattern. On multivariate analysis, histological subtypes other than liposarcoma (OR = 4.57, p = 0.02) and infiltrative border on MRI (OR = 2.48, p = 0.01) were independent factors associated with infiltrative histologic growth pattern. Predictive index based on these two factors showed a significant improved accuracy (ROC-AUC = 0.647) for predicting infiltrative histologic growth pattern compared to either factor alone. Our data suggests that liposarcoma histology and tumor border on MRI can predict histologic growth pattern in extremity STS.
Figures



Similar articles
-
Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.PLoS One. 2017 Jul 20;12(7):e0181787. doi: 10.1371/journal.pone.0181787. eCollection 2017. PLoS One. 2017. PMID: 28727824 Free PMC article.
-
Focus on the tumour periphery in MRI evaluation of soft tissue sarcoma: infiltrative growth signifies poor prognosis.Sarcoma. 2006;2006:21251. doi: 10.1155/SRCM/2006/21251. Epub 2006 Dec 6. Sarcoma. 2006. PMID: 17496992 Free PMC article.
-
Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.Eur J Surg Oncol. 2014 Apr;40(4):406-11. doi: 10.1016/j.ejso.2013.12.010. Epub 2013 Dec 25. Eur J Surg Oncol. 2014. PMID: 24388741
-
Margin Assessment in Soft Tissue Sarcomas: Review of the Literature.Cancers (Basel). 2021 Apr 2;13(7):1687. doi: 10.3390/cancers13071687. Cancers (Basel). 2021. PMID: 33918457 Free PMC article. Review.
-
Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin.Adv Ther. 2017 Jul;34(7):1556-1571. doi: 10.1007/s12325-017-0561-4. Epub 2017 May 25. Adv Ther. 2017. PMID: 28547734 Free PMC article. Review.
Cited by
-
Identification of Malignancy in Peritumoral Edema in Soft Tissue Sarcoma: A Novel Targeted Molecular Approach.Ann Surg Oncol. 2025 Mar;32(3):1511-1521. doi: 10.1245/s10434-024-16521-0. Epub 2024 Nov 18. Ann Surg Oncol. 2025. PMID: 39556178
References
-
- Trovik C. S. Local recurrence of soft tissue sarcoma. a Scandinavian sarcoma group project. Acta Orthopaedica Scandinavica. 2001;72(300):1–31. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources